1. Home
  2. GUG vs BVS Comparison

GUG vs BVS Comparison

Compare GUG & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guggenheim Active Allocation Fund of Beneficial Interest

GUG

Guggenheim Active Allocation Fund of Beneficial Interest

HOLD

Current Price

$15.96

Market Cap

511.2M

Sector

Finance

ML Signal

HOLD

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$7.69

Market Cap

482.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GUG
BVS
Founded
2021
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
511.2M
482.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GUG
BVS
Price
$15.96
$7.69
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.50
AVG Volume (30 Days)
108.9K
260.4K
Earning Date
01-01-0001
11-04-2025
Dividend Yield
9.67%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.15
Revenue
N/A
$563,829,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.11
P/E Ratio
N/A
$50.14
Revenue Growth
N/A
1.58
52 Week Low
$12.71
$5.81
52 Week High
$15.06
$11.25

Technical Indicators

Market Signals
Indicator
GUG
BVS
Relative Strength Index (RSI) 70.84 53.84
Support Level $15.24 $7.56
Resistance Level $15.42 $8.18
Average True Range (ATR) 0.15 0.31
MACD 0.06 0.02
Stochastic Oscillator 94.81 53.85

Price Performance

Historical Comparison
GUG
BVS

About GUG Guggenheim Active Allocation Fund of Beneficial Interest

Guggenheim Active Allocation Fund is a diversified closed-end management investment company. The fund's investment objective is to maximize total return through a combination of current income and capital appreciation. The company invests in both fixed-income and other debt instruments selected from a variety of sectors and credit qualities, and may also invest in equities. It uses tactical asset allocation models to determine the optimal allocation of its assets between fixed-income and equity securities. A majority of its investments are made in corporate bonds and the rest in senior floating rate interests, asset-backed securities, preferred stocks, and other securities.

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Share on Social Networks: